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ABSTRACT: The structure of the protein complex CysM-CysO from a new cysteine biosynthetic pathway
found in the H37Rv strain of Mycobacterium tuberculosis has been determined at 1.53 Å resolution.
CysM (Rv1336) is a PLP-containing  -replacement enzyme and CysO (Rv1335) is a sulfur carrier protein
with a ubiquitin-like fold. CysM catalyzes the replacement of the acetyl group of O-acetylserine by CysO
thiocarboxylate to generate a protein-bound cysteine that is released in a subsequent proteolysis reaction.
The protein complex in the crystal structure is asymmetric with one CysO protomer binding to one end
of a CysM dimer. Additionally, the structures of CysM and CysO were determined individually at 2.8
and 2.7 Å resolution, respectively. Sequence alignments with homologues and structural comparisons
with CysK, a cysteine synthase that does not utilize a sulfur carrier protein, revealed high conservation
of active site residues; however, residues in CysM responsible for CysO binding are not conserved.
Comparison of the CysM-CysO binding interface with other sulfur carrier protein complexes revealed a
similarity in secondary structural elements that contribute to complex formation in the ThiF-ThiS and
MoeB-MoaD systems, despite major differences in overall folds. Comparison of CysM with and without
bound CysO revealed conformational changes associated with CysO binding.
CysM (Rv1336) and CysO (Rv1335) are two proteins that
participate in a recently discovered cysteine biosynthesis
pathway in Mycobacterium tuberculosis (1). In this pathway
CysO thiocarboxylate displaces the acetyl group of O-
acetylserine in a reaction catalyzed by the pyridoxal 5′-
phosphate (PLP)
1 dependent CysM protein. An N-S acyl
shift, followed by Mec+ (Rv1334) catalyzed hydrolysis
generates cysteine (Figure 1). This pathway stands in contrast
to the widely used sulﬁde-dependent cysteine biosynthesis
pathway also present in M. tuberculosis (CysK) and may be
of importance in the oxidizing environment of the macro-
phage (2-6) because thiocarboxylates are much more
resistant to oxidation than sulﬁde. Consistent with this, the
genes for CysM and CysO are upregulated when the
organism is exposed to oxidative stress (7).
Sulfur carrier proteins are structurally homologous to
ubiquitin (8) and have now been identiﬁed in the biosynthetic
pathways for cysteine (1), thiamin (9), molybdopterin (10),
and thioquinolobactin (11). Like ubiquitin, the sulfur carrier
protein is adenylated at a diglycyl C-terminus by a speciﬁc
activating protein. The adenylated C-terminus is subsequently
converted to a thiocarboxylate, which serves as the sulﬁde
source. Members of the sulfur carrier protein family have
diverse binding partners and show little sequence similarity.
ThiS is the sulfur carrier protein in thiamin biosynthesis and
is activated by ThiF (12). Thiocarboxylated ThiS, deoxy-D-
xylulose 5-phosphate, and glycine imine serve as substrates
for ThiG in the synthesis of the thiazole moiety of thiamin
(13). The sulfur carrier protein MoaD is found in the
molybdopterin biosynthetic pathway, and its activating
protein is MoeB (14). Crystal structures for the ThiF-ThiS
(15), ThiG-ThiS (16), MoeB-MoaD (17), and MoaE-MoaD
(10) complexes have been reported. An interesting variation
of a sulfur carrier protein is found in the biosynthetic pathway
of thioquinolobactin (18). In this system QbsE is the sulfur
carrier protein and QbsC is the adenylating protein. QbsE
has a diglycyl sequence followed by cysteine and phenyla-
lanine at its C-terminus. Clustered with the genes for these
two proteins is a gene for QbsD, a metal-dependent hydro-
lase, which cleaves the ﬁnal two amino acids from QbsE
generating the diglycyl C-terminus found in all of the other
sulfur carrier proteins.
We report here the X-ray crystal structure of the
CysM-CysO complex of the cysteine biosynthetic pathway
reﬁned to 1.53 Å resolution, the structure of CysM alone at
2.8 Å resolution, and the structure of CysO alone at 2.7 Å
resolution. The CysM-CysO complex is asymmetric with
one molecule of CysO binding to one end of a CysM dimer.
Conformational changes in CysM that occur upon complex
formation are described. The CysM-CysO interface is
compared to the binding interfaces for ThiF-ThiS, ThiG-
ThiS, MoeB-MoaD, MoaE-MoaD, and ubiquitin in complex
with the E1-like protein MMS2.
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Gene Cloning, OVerexpression, and Puriﬁcation. M.
tuberculosis DNA was a gift from Clifton Barry at the
National Institutes of Health. pET-16b and pET-28a plasmids
were purchased from Novagen. All plasmid DNA was
puriﬁed with a DNA miniprep kit from Promega. A Perkin-
Elmer GeneAmp PCR system 2400 and Platinum Pfx DNA
polymerase (Gibco Life Technologies) were used for PCR.
Primers were purchased from Integrated DNA Technologies.
Oligonucleotides were prepared using M. tuberculosis DNA
as a template for PCR, and sequencing was performed by
the Bioresource Center at Cornell University. DNA fragments
were puriﬁed by agarose gel electrophoresis followed by a
QIAquick gel extraction kit from Qiagen. T4 DNA ligase
was purchased from New England Biolabs. Escherichia coli
strain DH5R was used as a recipient for transformation,
propagation, and storage. Primers for the CysM plasmid were
engineered to introduce NdeI and BamHI restriction sites at
the 5′ and 3′ ends, respectively. The forward primer was
5′-GGG TGA GCG GAG CAT ATG ACA CGA TAC GAC-
3′. The reverse primer was 5′-TTC GGA TCC GGC GGA
TCC TCA TGC CCA TAG-3′. Primers for the CysO plasmid
were engineered to introduce NdeI and XhoI restriction sites
at the 5′ and 3′ ends, respectively. The forward primer was
5′-CCG AGA AAG GCC CAT ATG AAC GTC ACC GTA-
3′. The reverse primer was 5′-TCG TGT CAT GTG CTC
GAG TCA CCC ACC GGC-3′.
The CysM construct was transformed into B834(DE3)
methionine auxotrophic E. coli (Novagen) for overexpression.
Minimal media used for overexpression of B834(DE3) cells
were prepared by dissolving 11.28 g of M9 salts along with
40 mg/L of each amino acid excluding methionine, which
was replaced by selenomethionine at 50 mg/L. The ﬁnal
media also contained 0.4% (w/v%) glucose, 0.1 mM CaCl2,
2 mM MgSO4, 25 mg/mL FeSO4, 100 mg/L ampicillin, and
10 mL of 100× MEM vitamin solution (Invitrogen). Starter
cultures were prepared by growing cells in 20 mL of LB
media and then spinning the cells at 4800g for 5 min. The
LB supernatant was decanted and the cell pellet resuspended
with 20 mL of minimal media to inoculate1Lo fminimal
media. Cells were grown at 37 °C until an OD600 of 1.0 was
reached, followed by induction using 1 mM isopropyl  -D-
thiogalactopyranoside for 16-1 8ha t1 8°C. Cell pellets were
collected by centrifugation at 6400g for 7 min and placed
into a beaker containing 50 mL of a lysis buffer composed
of 5 mM imidazole, 0.5 M NaCl, and 20 mM Tris at pH 7.9
to be lysed using sonication. Cell lysate was separated from
the insoluble cell particles by centrifugation at 58000g at 4
°C for 20 min. The supernatant was run over a Ni-NTA
afﬁnity column equilibrated with lysis buffer. The column
was washed with lysis buffer containing 60 mM imidazole
and eluted with lysis buffer containing 1 M imidazole. The
eluate was buffer exchanged into 20 mM pH 7.9 Tris and 5
mM 1,4-dithiothreitol (DTT) using size exclusion chroma-
tography columns (Bio-Rad DG) with a molecular mass
cutoff of 6 kDa. A centrifugal ﬁlter (Amicon Ultra) with a
molecular mass cutoff of 10 kDa was used to concentrate
the solution by spinning at 5000g at 4 °C. The ﬁnal protein
concentration was 10-20 mg/mL as measured using the
Bradford assay (19). SDS-PAGE analysis showed a purity
of greater than 95%. Native CysM and CysO were trans-
formed into BL21(DE3) cells, overexpressed in LB media,
and puriﬁed as described above, without the use of DTT.
In an attempt to improve crystallization of CysM alone, a
putative surface residue in CysM (Lys204) was mutated to
alanine using site-directed mutagenesis. Previous studies have
shown that mutation of ﬂexible surface residues can lead to
reduced surface entropy and improvement in crystal quality
(20). A standard PCR protocol using PfuTurbo DNA
polymerase per the manufacturer’s instructions (Invitrogen)
and DpnI (New England Biolabs) to digest the methylated
parental DNA prior to transformation was used. The forward
primer was 5′-GCA CGT TGC CAA CGT CGC GAT CGT
GGC GGC CGA ACC CCG C-3′, and the reverse primer
was 5′-GCG GGG TTC GGC CGC CAC GAT CGC GAC
GTT GGC AAC GTG C-3′. Clones were screened by
restriction digest for the introduction of a PVuI site. A
representative clone with the correct restriction pattern was
sequenced by the Bioresource Center at Cornell University.
Protein Crystallization and Cryoprotection. A solution of
native CysM-CysO was prepared by mixing separate 15
mg/mL solutions each of CysO and CysM in a 2:1 volumetric
ratio. This solution was screened using the hanging drop
vapor diffusion method. Individual crystals grew in a range
of 7-10% PEG 4000 (w/v %), 0.1 M sodium citrate, pH
5.8, and 0.2 M ammonium acetate at 22 °C. Selenomethion-
ine crystals grew in the same conditions with 5 mM DTT.
Crystals were green in color and grew to 150 × 150 × 50
µm3 within 2-4 weeks. The K204 mutant was also screened
using the hanging drop method with a 10 mg/mL protein
FIGURE 1: The new cysteine biosynthetic pathway in M. tuberculosis. All early intermediates are bound to the CysM-CysO complex;
however, it is possible that the CysO-thioester adduct is released from CysM before the S-N acyl shift occurs to generate cysteinylated
CysO.
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proximately 100 × 40 × 20 µm3 in 2-4 weeks using the
hanging drop method in 0.1 M HEPES, pH 7.1, and 0.64 M
Li2SO4 at 22 °C. Crystals of CysO were grown using the
hanging drop method in the presence of the activating protein
MoeZ (Rv3206). MoeZ was puriﬁed as described previously
(1). A solution of native MoeZ-CysO was prepared by
mixing separate 10 mg/mL solutions each of MoeZ and CysO
in a 1:1 volumetric ratio. Crystals appeared in 0.2 M NaNO3
and 20% (w/v %) PEG 3350 after approximately 6 months
as colorless thick plates with dimensions of 200 × 40 × 40
µm3. Preliminary analysis of the X-ray diffraction data
showed that these crystals contained only CysO.
Cryoprotection of the CysM-CysO complex and CysM
K204A mutant crystals was carried out through sequential
dipping into well solutions with increasing concentrations
of ethylene glycol. The cryosolution for the selenomethionine
derivative and native CysM-CysO crystals contained 9%
PEG 4000, 0.1 M sodium citrate, pH 5.8, 0.2 M ammonium
acetate, 1 mM DTT, and either 5% or 25% ethylene glycol
by volume. Crystals were ﬁrst looped out of the mother liquor
and then placed in the 5% ethylene glycol solution for
approximately 10 s, followed by dipping into the 25%
ethylene glycol solution for another 10 s. The crystal was
then looped out of the 25% solution and plunged into liquid
nitrogen for storage. Cryoprotection of the K204A CysM
mutant was also done using sequentially increasing concen-
trations of ethylene glycol. CysM crystals were ﬁrst dipped
into a solution with 5% ethylene glycol, 0.64 M Li2SO4, and
0.1 M HEPES, pH 7.1, followed by dipping into the same
cryosolution with 25% ethylene glycol for approximately 10 s
each. Crystals of CysO were cryoprotected by dipping into
a solution of 0.2 NaNO3, 20% PEG 3350, and 25% PEG
400 for approximately 10 s before plunging into liquid
nitrogen.
X-ray Data Collection. Data for the selenomethionine
derivative CysM-CysO crystal were collected at the 24-
ID-C beamline at the Advanced Photon Source to 2.1 Å
resolution. The energy was calibrated with Se foil, and an
X-ray ﬂuorescence scan was done on the CysM-CysO
crystal to determine the absorption edge. Images were taken
using a Quantum ADSC Q315 detector (Area Detectors
Systems Corp.) for 720 frames with 1° oscillations in 10°
wedges. Native data for the CysM K204A and CysM-CysO
complex crystals were collected at the 8-BM beamline at
APS using 1° oscillations for 140° and 300°, respectively,
using a Quantum ADSC Q315 detector. Data for the CysO
crystals were collected using a Rigaku RTP 300 RC rotating
copper anode generator operating at 50 kV and 100 mA. A
Rigaku RAXIS IV++ image plate detector was used for
image detection. Data collection was done in 1° oscillations
for a total of 215°. Data collection statistics for all data sets
are summarized in Table 1. Integration and scaling of all
data was done using the HKL2000 suite of programs (21).
Structure Determination and Reﬁnement. Selenium sites
in the selenomethionine derivative CysM-CysO crystal were
found using SOLVE (22), with 11 of the 14 possible
selenium peaks located. Density modiﬁcation (23) and
automated model building (24) were done using RESOLVE.
The remainder of the model was built using the graphics
programs O (25) and Coot (26). Reﬁnement was carried out
using the CCP4 (27) and CNS (28) suite of programs. The
selenomethionine derivative structure was then reﬁned
against the higher resolution native CysM-CysO data. The
native CysM-CysO data set had low completeness in the
resolution range of 6 Å and below due to intensity overloads.
To account for this, the native CysM-CysO data set was
merged with data corresponding to a resolution of6Åa n d
below from the selenomethionine derivative crystal in
Scalepack (21) for reﬁnement and map calculations. In the
ﬁnal stages of reﬁnement, the high-resolution data alone were
used to reﬁne the model. All residues in all three molecules
were modeled into the electron density with the exception
of the N-terminal methionine residue of CysO and residues
126-129 in the CysM chain that does not interact with CysO
(CysMB). Six residues were modeled in alternate conforma-
tions: Leu169 from the CysM molecule that interacts with
CysO (CysMA), Cys99, Met190, Thr257, and Leu270 from
CysMB, and Thr9 from CysO.
The structure of CysMA was used as an initial model to
reﬁne against the K204A CysM data. Residues 212-226 and
315-323 from chain A and 313-326 from chain B were
not modeled due to disorder in the electron density maps.
The reﬁned structure of CysO from the CysM-CysO
complex was used as an initial model to reﬁne the CysO
only data. All but residues 91-93 were built into the model.
The ﬁnal reﬁnement statistics for all data sets and the
Table 1: Data Collection Statistics
sample SeMet CysOM native CysOM
a K204A CysM native CysO
source APS 24-ID-C APS 8-BM APS 8-BM home
wavelength (Å) 0.97950 0.97949 0.94980 1.54178
resolution (Å) 2.10 1.53 2.80 2.70
space group P21 P21 P212121 C2
unit cell parameters
a (Å) 56.2 55.8 72.4 87.9
b (Å) 80.6 80.4 85.4 62.9
c (Å) 91.5 89.6 98.9 36.5
  (deg) 106.8 105.8 90 114.6
no. of reﬂections 650381 334177 875722 20088
no. of unique reﬂections 45147 110648 15513 5022
redundancy 14.4 (12.0) 3.0 (2.5) 5.5 (5.3) 4.0 (3.0)
completeness 98.9 (92.5) 96.3 (81.6) 99.6 (96.2) 99.2 (95.4)
Rsym
b (%) 7.8 (30.9) 4.6 (21.9) 8.0 (24.7) 14.5 (39.2)
I/σ(I) 40.1 (6.6) 26.2 (4.0) 18.6 (4.1) 14.5 (3.5)
a Merged with low-resolution data from the SeMet crystal.
b Rsym ) ∑∑i|Ii - 〈I〉|/∑〈I〉, where 〈I〉 is the mean intensity of the N reﬂections with
intensities Ii and common indices hkl.
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PROCHECK (29) are shown in Table 2.
Molecular Modeling of Intermediates. The program Macro-
Model, version 9.1 (30, 31) was used to model both the
O-acetylserine (OAS)-PLP adduct 3, the R-aminoacrylate
intermediate 5, and intermediate 6. All water molecules were
removed from the structure, and the C-terminus of CysO
was converted to a thiocarboxylate and manually adjusted
to point toward the active site. Hydrogen atoms were added
where appropriate. The initial position of each intermediate
was approximated by overlaying the structure of O-
acetylserine sulfhydrylase from Salmonella typhimurium
containing an external aldimine linkage to methionine (32)
with CysM and superimposing their respective aldimine CR
and carboxylate atoms. Modeling was carried out using a
20 Å shell surrounding the OAS moiety of the adduct, with
residues withina6Åshell allowed to move and the
remaining residues frozen. Some of the key residues in the
conformational search included 91-AGG-93 from CysO and
184-GTTGT-188, Lys51, Ser265, and 322-WA-323 from
CysM. Torsional rotation was allowed between all atoms
within the PLP-OAS adduct connected by a single bond in
the conformational search parameters. Modeling was done
using the AMBER* force ﬁeld (33, 34) and a distance-
dependent electrostatic treatment with a dielectic constant
of 4.0. The TNCG minimization method was used for the
energy minimization of structures generated by conforma-
tional search (35). Conformational searching with the R-
aminoacrylate intermediate was done in the same way. The
ﬁnal models were manually adjusted to optimize the expected
reaction geometry.
Figure Preparation. All ﬁgures of protein molecules and
residues were generated in PyMOL (36).
RESULTS
CysM Structure. The CysM molecule is composed of eight
R-helices, ﬁve 310-helices, and nine  -strands (Figure 2A,B).
The protomer has a large and a small domain, each with an
R R sandwich fold. The large domain has a mixed  -sheet
with  1v 2V 9V 6V 7V 8V topology, while the smaller domain
consists of a three-stranded parallel  -sheet comprised of
strands  3,  4, and  5. This topology is consistent with other
 -elimination enzymes (37). The interface between CysM
molecules consists of loop regions with 60% of the residues
being hydrophobic at the dimer interface. Other interactions
include a salt bridge between Arg3 and Glu175 and a series
of hydrogen-bonding pairs that are listed in Table 3.
CysO Structure. The CysO monomer is 93 residues in
length and 9.6 kDa in mass. The secondary structure consists
of two 310 helices, a mixed four-stranded  -sheet with a
 3v 4V 1V 2v topology, and one R-helix inserted between
 2 and  3 (Figure 2C,D). This topology describes the  -grasp
fold that is seen in the sulfur carrier proteins ThiS (15) and
MoaD (17) as well as ubiquitin (38).
CysM-CysO Complex. The asymmetric CysM-CysO
complex consists of a CysM dimer with a CysO molecule
bound to one end (CysMA denotes the protomer interacting
with CysO, and CysMB denotes the unbound protomer)
(Figure 2E). It is unclear whether or not the asymmetric
complex is an artifact of crystallization. Native analytical
gel analysis was inconclusive, and attempts to purify the
complex suggest that CysO is weakly bound to CysM
(unpublished data). The CysMA and CysMB protomers show
two main differences. First, the loop region spanning residues
211-237 in CysMA contains three 310-helices and extends
away from the core of the structure to accommodate CysO
binding. CysMB adopts a more compact structure with an
R-helix spanning residues 217-222 and a single 310-helix
spanning residues 228-231. Second, the smaller domain
comprising strands  3,  4, and  5 and helix R4 is shifted
away from the core of the complex structure. Only the
conformation of the CysO binding loop in CysMA allows
for hydrogen bonds to form between the region connecting
 5 and R4 in the smaller domain. The hydrogen bonds that
contribute to this shift in CysMA are between the carboxylic
acid side chain from Glu126 and the carbonyl oxygen atom
of Ala218 and between the amide nitrogen atom of Gly217
and the carbonyl oxygen atom of Val216.
The comparison between CysO molecules from the
complex structure and the CysO alone structure shows that
the overall structure remains the same, with a root-mean-
square deviation (rmsd) between 89 CR carbon atoms of 0.5
Å. One main difference is that the C-terminus of CysO in
the complex is well ordered through several hydrogen bonds
with CysM. The absence of CysM binding leads to disorder
in the ﬁnal three residues of CysO alone, which were not
modeled into the structure. Twenty-ﬁve percent of the
accessible surface of CysO is buried in the complex as
calculated by the protein-protein interaction server (39). Key
hydrogen bonds between CysO and CysM are listed in Table
4. The side chain oxygen atom of Asp65CysO is hydrogen
bonded to His271A through a bridging water molecule
(subscripts CysO and A refer to CysO and CysMA, respec-
tively). A bridging water molecule is found donating
hydrogen bonds to the carbonyl oxygen atoms of both
Gly92CysO and Leu183A, and two bridging water molecules
form a hydrogen-bonding network connecting the carbonyl
oxygen atoms of Val90CysO and Phe226A. Two salt bridges
also occur at the protein-protein interface between Arg12CysO
and Glu214A and between Asp65CysO and Arg211A.
ActiVe Site. A PLP cofactor is found in each protomer of
CysM covalently attached to Lys51 through a Schiff base
linkage. Figure 3 illustrates key interactions between CysM
and PLP. A glycine- and threonine-rich sequence binds the
Table 2: Reﬁnement Statistics
sample
SeMet
CysOM
native
CysOM
K204A
CysM
native
CysO
no. of non-H atoms 5529 6512 4648 1290
no. of protein atoms 5150 5454 4443 1266
no. of water atoms 349 1028 160 24
no. of ligand atoms 30 30 45 0
Rworking (%)
a 19.2 17.6 19.0 19.5
Rfree (%)
b 24.3 21.7 25.6 25.2
Ramachandran plot
most favored region (%) 89.7 91.7 89.4 89.0
additionally allowed
regions (%)
7.5 7.9 8.6 11.0
generously allowed
region (%)
1.9 0.3 1.6 0.0
disallowed region (%) 0.9 0.0 0.4 0.0
rms deviations from ideal
bonds (Å) 0.021 0.026 0.021 0.019
angles (deg) 2.0 2.2 2.0 2.0
a Rworking ) Σ||Fo| - K|Fc||/Σhkl|Fo|, where Fo and Fc are the observed
and calculated structure factors, respectively.
b Rfree was calculated using
5% of all reﬂections that were excluded at all stages of reﬁnement.
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(40). A large area of open space occupied only by water
molecules spans the distance between Gly93 of CysO and
the PLP molecule. The distance from the Schiff base forming
carbon atom of PLP to the closest C-terminal oxygen atom
of CysO is 11.3 Å.
DISCUSSION
CysM and Structural Homologues. Structural homologues
were identiﬁed using the DALI server (www.ebi.ac.uk/dali),
and the top hits were selected for comparison (Table 5). The
closest structural homologues are  -elimination enzymes,
which use OAS or phosphoserine as a substrate to make
cysteine. CysK, the sulﬁde-dependent cysteine synthase, has
rmsd values of 2.4 Å for 281 CR carbon atoms from CysMA
and 1.8 Å for 278 CR carbon atoms from CysMB. S.
typhimurium O-acetylserine sulfhydrylase (OASS) has rmsd
values of 2.5 Å for 287 CR carbon atoms from CysMA and
1.9 Å for 283 CR carbon atoms from CysMB. The conforma-
tion of the CysO binding loop of CysM is the most signiﬁcant
FIGURE 2: Structures of CysM and CysO. (A) CysM ribbon diagram. (B) CysM topology. (C) CysO ribbon diagram. (D) CysO topology
diagram. (E) Ribbon diagram of the CysM-CysO complex. CysM bound to CysO (CysMA) is color coded with red helices, yellow strands,
and green loops. CysO and CysM not bound to CysO (CysMB) are color coded with cyan helices, magenta strands, and salmon loops.
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bind a sulfur carrier protein. The conformation of the binding
loop in CysMB is more similar to the structural homologues
than in CysMA, which results in the lower rmsd values.
Another structural difference is that the C-terminal tail of
CysM encompassing residues 300-323 contains two 310-
helices and points directly into the active site. Both the CysK
and OASS structures lack this N-terminal extension.
CysM and CysK ActiVe Sites. The PLP binding geometries
of CysM and CysK are very similar (Figure 4). The ﬁnal
two residues of CysM, Trp322 and Ala323, point toward
the active site of the protein. A π-stacking interaction
between Trp322 and Tyr212 helps to position the C-terminus.
Residues 218-222, rather than the C-terminus, occupy this
region in CysK. These residues correspond to the CysO
binding loop of CysM based on sequence alignment. Ad-
ditionally, there is a molecule of 2-methyl-2,4-pentanediol
in CysK corresponding to the region of CysM spanning the
C-terminus of CysO and the PLP cofactor. The C-terminus
of the CysM K204A mutant also does not point to the active
site. However, the CysO binding loop of one of the K204A
protomers is seen ordered and has the same conformation
as the corresponding residues in CysK.
CysO and Structural Homologues. Structural homologues
were identiﬁed using the DALI server and selecting the top
hits for comparison (Table 6). The  -grasp proteins complexed
with a binding partner were also used for comparison. This
included ThiS, MoaD, and ubiquitin, which were compared to
CysO through structural superposition. Each possesses the same
topology, with most structural differences found in loop regions
Table 3: Dimeric Interactions
A chain B chain H-bond atoms
Thr2 Asp172 OH-Oδ
Tyr4 Leu16 NH-O
Tyr4 Gly18 O-NH
Asp5 Gln20 O-NH
Leu92 Arg21 O-NH1
Gln111 Leu301 NH-O
Leu115 His256 O-NH
Tyr116 Gly259 OH-O
Asp172 Arg3 O-NH1
Glu175 Arg3 O-NH1
His256 Arg91 O-N
Table 4: CysM-CysO Hydrogen Bonds
CysM CysO H-bond atoms
Asn130 Ala89 NHδ-O
Asn130 Ala91 O-HN
Glu209 Tyr62 O-HO
Tyr217 Gly93 OH-O
Phe226 Ala89 NH-O
Arg239 Asp67 O-HN
Ser241 Asp65 OH-Oδ
FIGURE 3: CysM active site with PLP coordinating residues labeled
with green carbon atoms.
Table 5: CysM Structural Homologues
PDB
code Z-score
aligned
CR atoms rmsd annotation
2Q3B 34.8 281 2.4 cysteine synthase
1OAS 34.2 287 2.5 O-acetylserine sulfhydrylase
1WKV 32.7 278 2.0 O-phosphoserine sulfhydrylase
2TYS 27.9 274 2.7 tryptophan synthase
1TDJ 25.9 271 2.9 threonine deaminase
1V71 24.7 267 3.2 serine racemase
1PWE 23.9 264 3.4 serine dehydratase
1F2D 22.9 262 2.7 1-aminocyclopropane-1-
carboxylate deaminase
1E5X 21.7 269 3.6 threonine synthase
1KL7 20.7 269 3.5 threonine synthase
FIGURE 4: Schematic representation of CysM (A) and CysK (B)
binding interactions with the PLP cofactor.
Table 6: CysO Structural Homologues
PDB
code Z-score
aligned
CR atoms rmsd annotation
1V8C 14.9 86 1.8 Thermus thermophilus MoaD
1FMA 9.5 78 2.3 MoaD from MoaE-MoaD complex
1JW9 8.9 77 2.8 MoaD from MoeB-MoaD complex
2GLE 8.9 82 2.9 neurabin SAM domain
1XO3 8.1 80 2.9 Mus musculus Urm1
2BB5 7.9 78 2.6 transcobalamin II
1C1Y 5.4 63 2.5 Ras-binding domain of c-Raf1
1ZUD 5.1 58 2.6 ThiS from ThiF-ThiS complex
1TYG 4.7 59 3.2 ThiS from ThiG-ThiS complex
1ZGU 4.4 62 2.6 ubiquitin from MMS2-Ub complex
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insertions spanning residues 7-19 and 48-55, which are absent
in the homologues. The exception is MoaD, which aligns well
with residues 7-19 in CysO. Both CysO and MoaD form a
key binding interaction with their respective binding partner in
this region. The rmsd values between CR positions in CysO
are 2.6 Å for ThiS for 58 CR carbon atoms, 2.8 Å for MoaD
for 77 CR carbon atoms, and 2.6 Å for ubiquitin for 62 CR
carbon atoms.
CysM-CysO Interactions and ConserVed Residues. The
features required for interactions with CysO come from three
main sections of the CysM molecule. First is the CysO
binding loop encompassing residues 211-237, which con-
tributes the majority of CysO binding interactions. Second
is helix R4, which is part of the smaller domain of the CysM
molecule. Asn130 from this helix forms one of the key
hydrogen bonds that stabilize the C-terminal region of CysO.
Third, strand  8 forms hydrogen bonds with the loop that
proceeds from the  3 strand of CysO.
In order to determine key CysM residues, sequence
alignments were performed using both homologues that
utilize sulfur carrier proteins and ones that incorporate sulfur
directly from sulﬁde. Residues Asn81 and Ser265 that bind
the PLP cofactor are exclusively conserved in both types.
The glycine- and threonine-rich sequence that binds the
phosphate group of the cofactor varies slightly in the position
of glycine and threonine or serine residues, but overall the
motif is conserved. A sequence alignment of 200 nonredun-
dant CysM sequences shows that none of the residues on
the CysM surface involved with CysO binding are conserved.
When the alignment is restricted to the organisms Myco-
bacterium Vanbaalenii, Mycobacterium smegmatis, Myco-
bacterium ulcerans, and Mycobacterium ﬂaVescens, all of
which have both CysO and CysM genes, the CysO binding
residues are exclusively conserved. Conservation of the
CysM-CysO binding interface is maintained within the
Mycobacterium genus but shows greater variation, especially
in CysM, for other species.
Comparison of the CysM-CysO Interface with Other
 -Grasp Protein Complexes. In order to determine if regions
FIGURE 5: Ribbon diagrams of all structurally characterized sulfur
carrier proteins and ubiquitin.
FIGURE 6: Ribbon and surface interface diagrams of CysO homologues in complexes with their binding partners. (A) ThiF-ThiS complex.
(B) ThiG-ThiS complex. (C) MoeB-MoaD complex. (D) MoaE-MoaD complex. (E) Ubiquitin-MMS2 complex. (F) CysM-CysO
complex. The sulfur carrier proteins are colored orange, and their respective binding partners are colored light blue. The silver colored
regions in each pair indicate the binding interface. Strands  3 and  4 are labeled for each sulfur carrier protein, which are all in the same
orientation. The comparison shows the diversity of binding partners that interact with the sulfur carrier protein fold.
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are similar to other  -grasp protein complexes, the structures
ThiF-ThiS (15) ThiG-ThiS (16), MoeB-MoaD (17),
MoaE-MoaD (10), and ubiquitin in complex with the E2-
like protein MMS2 (41) were compared in Figure 6. Table
7 lists several properties of the sulfur carrier proteins and
ubiquitin at the protein-protein interface. The percent of
hydrophobic residues at the interface ranges from 61% to
72% for the sulfur carrier protein examples, while the
ubiquitin-MMS2 structure falls below this range at 58%.
The number of hydrogen bonds between sulfur carrier
proteins and their binding partners ranges from 9 to 11, but
the ubiquitin-MMS2 structure has only 5. This is due to
ubiquitin having much less of its accessible surface area in
close contact with its binding partner. In the sulfur carrier
protein examples, 20-25% of the accessible surface area is
in close contact with each binding partner. In ubiquitin, only
13% of the surface makes up the binding interface with
MMS2.
Structural alignments were made by superimposing each
sulfur carrier protein or ubiquitin complex using only CysO
as the template. No structural similarities between CysM,
ThiG, MoaE, or MMS2 are observed. However, two  -strands
common to CysM, ThiF, and MoeB align when each sulfur
carrier protein is overlaid. The strands  7 and  8 in CysM
align with strands  6 and  7 in ThiF and MoeB despite the
fact that CysM has a different fold. The regions in the sulfur
carrier proteins and ubiquitin that make up most of the
binding interface come from strands  3 and  4 and the
residues following  4 to the C-terminus. The ubiquitin
complex structure has the smallest interface with only residue
42 from strand  3 and residue 68 from  4 contributing to
hydrogen bonds at the interface.
Mechanistic Implications. A mechanistic proposal for the
CysO-CysM-catalyzed reaction, based on the extensive
mechanistic characterization of the sulﬁde-dependent cysteine
synthase (42), is outlined in Scheme 1. In this proposal,
O-acetylserine forms an imine with PLP which then under-
goes a deprotonation to give 4. Acetate elimination followed
by thiocarboxylate addition to the resulting aminoacrylate
gives 6. The reaction is completed by a tautomerization to 7
followed by a transimination reaction to give thioester 8,
which then undergoes an N/S acyl shift to give cysteinyl-
CysO 9.
Molecular modeling simulations using conformational
searching followed by molecular mechanics based energy
Scheme 1
Table 7: Protein-Protein Interface Comparisons
protein interface parameter CysO-CysM ThiS-ThiF ThiS-ThiG MoaD-MoaB MoaD-MoaE Ub-MMS2
interface accessible surface area (Å2) 1213.6 1045.9 1194.2 1113.2 985.1 632.4
% interface accessible surface area 24.6 22.7 24.2 23.5 19.7 13.4
% polar atoms in interface 35.1 38.2 28.2 35.4 39.3 42.2
% nonpolar atoms in interface 64.8 61.7 71.7 64.6 60.6 57.8
hydrogen bonds 11 14 11 9 13 5
salt bridges 1 1 0 1 0 0
Structure of the M. tuberculosis CysM-CysO Complex Biochemistry, Vol. 47, No. 39, 2008 10361minimization, followed by manual optimization, were carried
out using MacroModel for both the PLP-OAS adduct 3 and
the R-aminoacrylate intermediate 5 in the active site. In the
PLP-OAS model (Figure 7A), the carboxylate moiety of
OAS accepts a hydrogen bond from the backbone nitrogen
atom of Asn81. One oxygen atom of the acetate moiety
accepts a hydrogen bond from the hydroxyl group of Tyr212
while the other accepts a hydrogen bond from the amide
nitrogen atom of Ala323. In the R-aminoacrylate model
(Figure 7B), the carboxylate moiety accepts hydrogen bonds
from the hydroxyl group of Tyr212 and the amide nitrogen
atom of Ala323. The conformation of the C-terminus of
CysO shows the sulfur atom at a distance of 3.7 Å from the
 -carbon R-aminoacrylate intermediate 5. Using the ami-
FIGURE 7: Stereoviews of the active site models. (A) The PLP-OAS adduct 3. (B) R-Aminoacrylate intermediate 5. (C) Intermediate 6 in
which the C-S bond has formed. CysM residues are labeled with magenta carbon atoms, CysO residues are labeled with green carbon
atoms and PLP and OAS or aminoacrylate moieties with cyan carbon atoms.
10362 Biochemistry, Vol. 47, No. 39, 2008 Jurgenson et al.noacrylate as a starting point, a model for the subsequent
intermediate 6 in which the carbon-sulfur bond has formed
was generated (Figure 7C).
The structural and modeling studies are consistent with
the mechanistic proposal in Scheme 1. PLP is bound at the
active site via an imine with Lys51. The model of the enzyme
O-acetylserine (OAS) complex (Figure 7A) shows Lys51
displaced by the amino group of OAS and that Lys51 could
serve as the base involved in the CR deprotonation. The
resulting carbanion is stabilized by delocalization into the
PLP cofactor as well as by delocalization into the OAS
carboxylate which forms multiple hydrogen-bonding interac-
tions with the enzyme (backbone amides of Asn81 and
Thr82, OH of Thr82). The acetate of OAS is reasonably
positioned for departure, after planarization of CR following
deprotonation, with the scissile C-O bond perpendicular to
the plane of the delocalized π system. This suggests an E1cB
mechanism rather than an E2 mechanism for this elimination
reaction, which occurs with trans stereochemistry. Acetate
is also activated as a leaving group by hydrogen bonding of
its carbonyl oxygen to the amide NH of threonine 185
(nonoptimal orientation in the model because CR is not yet
planarized). The thiocarboxylate sulfur is located 5.21 Å from
the carbon to which it will add. This large separation suggests
that, after acetate departs, the thiocarboxylate group of CysO
occupies the acetate binding site and that thiocarboxylate
addition is the microscopic reverse of acetate departure. This
predicts that the C  substitution reaction is occurring with
overall retention of stereochemistry.
The model of the aminoacrylate intermediate (Figure 7B)
shows the thiocarboxylate in position to add to the C  of
the aminoacrylate (C -S distance ) 2.48 Å). The thiocar-
boxylate occupies the acetate binding site but is not hydrogen
bonded to the amide NH of Thr185. This model also predicts
that the CR carbanion, generated after thiocarboxylate
addition, is stabilized by delocalization into the cofactor as
well as by delocalization into the C  carboxylate, which
forms hydrogen bonds with the amide NH and the side chain
OH of Thr82 and with the backbone nitrogen atom of Asn81.
Lys51 is reasonably positioned to protonate this carbanion
(CR-N distance ) 4.08 Å).
In the enzyme thioester model (Figure 7C), Lys51 is
reasonably positioned to mediate the transimination required
for product release. There are no hydrogen-bonding interac-
tions to the thioester carbonyl group whose carbon is held
4.89 Å from the cysteinyl amino group. This suggests that
the ﬁnal N/S acyl shift is not enzyme catalyzed and occurs
after dissociation of the thioester from CysM.
Conclusions. The structure of CysM-CysO is an example
of a  -elimination enzyme in complex with a sulfur carrier
protein used to generate the amino acid cysteine. CysM is
able to bind CysO using a binding loop that is ordered
differently in structural comparators and when CysO is
unbound. The binding loop contains residues that are only
conserved among other species within the Mycobacterium
genus that also utilize a sulfur carrier protein for cysteine
biosynthesis. The overall fold of CysO is similar to that of
other sulfur carrier proteins and ubiquitin. Two  -strands at
the interface of CysO and CysM are structurally aligned
when compared to the E1-like adenyltransferase proteins
ThiF and MoaD. Modeling studies show that the C-terminus
of CysO is able to reach the  -carbon of the R-aminoacrylate
intermediate in a conformation favorable for nucleophilic
addition and that cysteine formation proceeds by a mecha-
nism that is similar to that used by the sulﬁde-dependent
cysteine synthase.
ACKNOWLEDGMENT
We thank Leslie Kinsland for help in the preparation of
the manuscript and Dr. Igor Kourinov and the rest of the
NE-CAT staff at the APS beamlines 24-ID-C and 8-BM for
receiving crystal samples and collecting several CysM-CysO
data sets. We thank Drs. Angela Toms and Erika Soriano
for collecting the native CysM-CysO and K204A CysM
mutant data sets.
REFERENCES
1. Burns, K. E., Baumgart, S., Dorrestein, P. C., Zhai, H., McLafferty,
F. W., and Begley, T. P. (2005) Reconstitution of a new cysteine
biosynthetic pathway in Mycobacterium tuberculosis. J. Am. Chem.
Soc. 127, 11602–11603.
2. Kusner, D. J. (2005) Mechanisms of mycobacterial persistence in
tuberculosis. Clin. Immunol. 114, 239–247.
3. Li, Z., Kelley, C., Collins, F., Rouse, D., and Morris, S. (1998)
Expression of katG in Mycobacterium tuberculosis is associated
with its growth and persistence in mice and guinea pigs. J. Infect.
Dis. 177, 1030–1035.
4. Russell, D. G. (2003) Phagosomes, fatty acids and tuberculosis.
Nat. Cell Biol. 5, 776–778.
5. Vachula, M., Holzer, T. J., and Andersen, B. R. (1989) Suppression
of monocyte oxidative response by phenolic glycolipid I of
Mycobacterium leprae. J. Immunol. 142, 1696–1701.
6. Vergne, I., Chua, J., Singh, S. B., and Deretic, V. (2004) Cell
biology of Mycobacterium tuberculosis phagosome. Annu. ReV.
Cell. DeV. Biol. 20, 367–394.
7. Manganelli, R., Voskuil, M. I., Schoolnik, G. K., Dubnau, E.,
Gomez, M., and Smith, I. (2002) Role of the extracytoplasmic-
function sigma factor sigma(H) in Mycobacterium tuberculosis
global gene expression. Mol. Microbiol. 45, 365–374.
8. Vijay-Kumar, S., Bugg, C. E., Wilkinson, K. D., and Cook, W. J.
(1985) Three-dimensional structure of ubiquitin at 2.8 Å resolution.
Proc. Natl. Acad. Sci. U.S.A. 82, 3582–3585.
9. Taylor, S. V., Kelleher, N. L., Kinsland, C., Chiu, H. J., Costello,
C. A., Backstrom, A. D., McLafferty, F. W., and Begley, T. P.
(1998) Thiamin biosynthesis in Escherichia coli. Identiﬁcation of
this thiocarboxylate as the immediate sulfur donor in the thiazole
formation. J. Biol. Chem. 273, 16555–16560.
10. Rudolph, M. J., Wuebbens, M. M., Rajagopalan, K. V., and
Schindelin, H. (2001) Crystal structure of molybdopterin synthase
and its evolutionary relationship to ubiquitin activation. Nat. Struct.
Biol. 8, 42–46.
11. Godert, A. M., Jin, M., McLafferty, F. W., and Begley, T. P. (2007)
Biosynthesis of the thioquinolobactin siderophore: an interesting
variation on sulfur transfer. J. Bacteriol. 189, 2941–2944.
12. Xi, J., Ge, Y., Kinsland, C., McLafferty, F. W., and Begley, T. P.
(2001) Biosynthesis of the thiazole moiety of thiamin in Escheri-
chia coli: identiﬁcation of an acyldisulﬁde-linked protein-protein
conjugate that is functionally analogous to the ubiquitin/E1
complex. Proc. Natl. Acad. Sci. U.S.A. 98, 8513–8518.
13. Begley, T. P., Downs, D. M., Ealick, S. E., McLafferty, F. W.,
Van Loon, A. P., Taylor, S., Campobasso, N., Chiu, H. J., Kinsland,
C., Reddick, J. J., and Xi, J. (1999) Thiamin biosynthesis in
prokaryotes. Arch. Microbiol. 171, 293–300.
14. Leimkuhler, S., Wuebbens, M. M., and Rajagopalan, K. V. (2001)
Characterization of Escherichia coli MoeB and its involvement in
the activation of molybdopterin synthase for the biosynthesis of
the molybdenum cofactor. J. Biol. Chem. 276, 34695–34701.
15. Lehmann, C., Begley, T. P., and Ealick, S. E. (2006) Structure of
the Escherichia coli ThiS-ThiF complex, a key component of the
sulfur transfer system in thiamin biosynthesis. Biochemistry 45,
11–19.
16. Settembre, E. C., Dorrestein, P. C., Zhai, H., Chatterjee, A.,
McLafferty, F. W., Begley, T. P., and Ealick, S. E. (2004) Thiamin
biosynthesis in Bacillus subtilis: structure of the thiazole synthase/
sulfur carrier protein complex. Biochemistry 43, 11647–11657.
Structure of the M. tuberculosis CysM-CysO Complex Biochemistry, Vol. 47, No. 39, 2008 1036317. Lake, M. W., Wuebbens, M. M., Rajagopalan, K. V., and
Schindelin, H. (2001) Mechanism of ubiquitin activation revealed
by the structure of a bacterial MoeB-MoaD complex. Nature 414,
325–329.
18. Godert, A. M., Jin, M., McLafferty, F. W., and Begley, T. P. (2007)
Biosynthesis of the thioquinolobactin siderophore: an interesting
variation on sulfur transfer. J. Bacteriol. 189, 2941–2944.
19. Bradford, M. M. (1976) A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal. Biochem. 72, 248–254.
20. Derewenda, Z. S. (2004) Rational protein crystallization by
mutational surface engineering. Structure 12, 529–535.
21. Otwinowski, Z., and Minor, W. (1997) Processing of x-ray
diffraction data collected in oscillation mode. Methods Enzymol.
276, 307–326.
22. Terwilliger, T. C., and Berendzen, J. (1999) Automated structure
solution for MIR and MAD. Acta Crystallogr. D 55, 849–861.
(http://www.solve.lanl.gov).
23. Terwilliger, T. C. (2000) Maximum likelihood density modiﬁcation.
Acta Crystallogr. D 56, 965–972.
24. Terwilliger, T. C. (2003) Automated main-chain model building
by template matching and iterative fragment extension. Acta
Crystallogr. D 59, 38–44.
25. Jones, T. A., Zou, J.-Y., Cowan, S. W., and Kjeldgaard, M. (1991)
Improved methods for the building of protein models in electron
density maps and the location of errors in these models. Acta
Crystallogr. A 47, 110–119.
26. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for
molecular graphics. Acta Crystallogr. D 60, 2126–2132.
27. Collaborative Computational Project-Number 4 (1994) The CCP-4
suite: programs for protein crystallography, Acta Crystallogr. D.
50, 760-763.
28. Bru ¨nger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros,
P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges,
M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and
Warren, G. L. (1998) Crystallography & NMR system: A new
software suite for macromolecular structure determination. Acta
Crystallogr. D 54, 905–921.
29. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton,
J. M. (1993) PROCHECK: a program to check the stereochemical
quality of protein structures. J. Appl. Crystallogr. 26, 283–291.
30. Mohamadi, F., Richards, N. G. J., Guida, W. C., Liskamp, R.,
Lipton, M., Cauﬁeld, C., Chang, G., Hendrickson, T., and Still,
W. C. (1990) MacroModelsAn Integrated Software System for
Modeling Organic and Bioorganic Molecules Using Molecular
Mechanics. J. Comput. Chem. 11, 460–467.
31. MacroModel, v. (2005) Schrodinger, LLC, New York, NY.
32. Burkhard, P., Tai, C. H., Ristroph, C. M., Cook, P. F., and
Jansonius, J. N. (1999) Ligand binding induces a large conforma-
tional change in O-acetylserine sulfhydrylase from Salmonella
typhimurium. J. Mol. Biol. 291, 941–953.
33. Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ghio, C.,
Alagona, G., Profeta, S., Jr., and Weiner, P. (1984) A new force
ﬁeld for molecular mechanical simulation of nucleic acids and
proteins. J. Am. Chem. Soc. 106, 765–784.
34. Weiner, S. J., Kollman, P. A., Nguyen, D. T., and Case, D. A.
(1986) An all atom force ﬁeld for simulations of proteins and
nucleic acids. J. Comput. Chem. 7, 230–252.
35. Ponder, J. W., and Richards, F. M. (1987) An efﬁcient Newton-
like method for molecular mechanics energy minimization of large
molecules. J. Comput. Chem. 8, 1016–1024.
36. DeLano, W. L. (2002)The PyMOL User’s Manual.
37. Burkhard, P., Rao, G. S., Hohenester, E., Schnackerz, K. D., Cook,
P. F., and Jansonius, J. N. (1998) Three-dimensional structure of
O-acetylserine sulfhydrylase from Salmonella typhimurium. J. Mol.
Biol. 283, 121–133.
38. Vijay-Kumar, S., Bugg, C. E., Wilkinson, K. D., and Cook, W. J.
(1985) Three-dimensional structure of ubiquitin at 2.8 Å resolution.
Proc. Natl. Acad. Sci. U.S.A. 82, 3582–3585.
39. Jones, S., and Thornton, J. M. (1995) Protein-protein interactions:
a review of protein dimer structures. Prog. Biophys. Mol. Biol.
63, 31–65.
40. Momany, C., Ghosh, R., and Hackert, M. L. (1995) Structural
motifs for pyridoxal-5′-phosphate binding in decarboxylases: an
analysis based on the crystal structure of the Lactobacillus 30a
ornithine decarboxylase. Protein Sci. 4, 849–854.
41. Lewis, M. J., Saltibus, L. F., Hau, D. D., Xiao, W., and
Spyracopoulos, L. (2006) Structural basis for non-covalent interac-
tion between ubiquitin and the ubiquitin conjugating enzyme variant
human MMS2. J. Biomol. NMR 34, 89–100.
42. Tai, C. H., and Cook, P. F. (2001) Pyridoxal 5′-phosphate-
dependent alpha,beta-elimination reactions: mechanism of O-
acetylserine sulfhydrylase. Acc. Chem. Res. 34, 49–59.
BI800915J
10364 Biochemistry, Vol. 47, No. 39, 2008 Jurgenson et al.